English
Regional settings| Spread | 0.034 | ||||
 Long position overnight feeLong position overnight fee
Trade size with leverage ~ SGD 5,000.00 Short position overnight fee ~ SGD 4,000.00 | -0.020845% | ||||
| Short position overnight fee Short position overnight fee
Trade size with leverage ~ SGD 5,000.00 Short position overnight fee ~ SGD 4,000.00 | -0.001073% | ||||
| Overnight fee time | 21:00 (UTC) | ||||
| Currency | SGD | ||||
| Min traded quantity | 1 | ||||
| Margin | 20 | ||||
| Stock exchange | Singapore | ||||
| Commission on trade1 | 0% |
Information_provided_by_capital
1Our charge for executing your trade is the spread, the difference between the buy and sell price. Please consult the Charges and Fees section of our website for further information
| Prev. Close | 3.488 |
| Open | 3.478 |
| 1-Year Change | -11.21% |
| Day's Range | 3.478 - 3.548 |
Parkway Life Real Estate Investment Trust is a Singapore-based healthcare real estate investment trust (REIT). The principal activity of the Company is to invest primarily in income-producing real estate and/or real estate-related assets in the Asia-Pacific region, including Singapore that are used primarily for healthcare and/or healthcare-related purposes, including hospitals, healthcare facilities and real estate and/or real estate assets used for healthcare research, education, and the manufacture or storage of drugs, medicine and other healthcare goods and devices. Its segments include Hospital Properties, Nursing Home and Care Facility Properties and Medical Centre Units. Its portfolio includes about 56 properties. Its properties include Mount Elizabeth Hospital Property, Gleneagles Hospital Property, Parkway East Hospital Property, Bon Sejour Yokohama Shin-Yamashita, Palmary Inn Akashi, Sompo no le Nakasyo, Maison des Centenaire Haruki and Hapine Fukuoka Noke, among others.
BRIEF: For the fiscal year ended 31 December 2021, Parkway Life REIT revenues decreased less than 1% to SP$120.7M. Net income increased from SP$87.2M to SP$331.9M. Revenues reflect Hospital and Medical Centre segment increase of 1% to SP$70.7M, Singapore segment increase of 1% to SP$70.4M, also reflect Pharmaceutical Manufacturing and Distribution Facility segment decrease of 93% to SP$128K, Japan segment decrease of 2% to SP$50M.
11/2009, Capital repayment of SGD 0.0014 01/2010, Capital repayment of SGD 0.0018 05/2010, Capital repayment of SGD 0.0029 08/2010, Capital repayment of SGD .003 11/2010, Capital repayment of SGD .0044 01/2011, Capital repayment of SGD .0044
